# Proof of Concept (POC) in Patients With Ischaemic Stroke

Study · id `cardio:ct-nct01808261` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01808261](<https://clinicaltrials.gov/study/NCT01808261>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01808261

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 134 participants.

## Technical summary

Registry record NCT01808261. Randomized; double masking; primary purpose treatment. Start 2013-05-18 (actual); primary completion 2014-07-28 (actual). Results posted on 2017-10-03.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 134 participants (enrolled count; ClinicalTrials.gov record NCT01808261, source copy `cardio:ctgov-nct01808261-2017-11-17`, retrieved 2026-10-26)
- Started: 2013-05-18 (actual) (ClinicalTrials.gov record NCT01808261, source copy `cardio:ctgov-nct01808261-2017-11-17`, retrieved 2026-10-26)
- Primary completion: 2014-07-28 (actual) (ClinicalTrials.gov record NCT01808261, source copy `cardio:ctgov-nct01808261-2017-11-17`, retrieved 2026-10-26)
- Completion: 2014-07-28 (actual) (ClinicalTrials.gov record NCT01808261, source copy `cardio:ctgov-nct01808261-2017-11-17`, retrieved 2026-10-26)
- Results first posted: 2017-10-03 (ClinicalTrials.gov record NCT01808261, source copy `cardio:ctgov-nct01808261-2017-11-17`, retrieved 2026-10-26)
- Countries: United States; Canada; Germany; United Kingdom (ClinicalTrials.gov record NCT01808261, source copy `cardio:ctgov-nct01808261-2017-11-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01808261-2017-11-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Proof of Concept (POC) in Patients With Ischaemic Stroke
- Condition: Cerebrovascular Accident
- Intervention (Drug): GSK249320 100/mg
- Intervention (Drug): Placebo
- Lead sponsor: GlaxoSmithKline
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: GlaxoSmithKline (`cardio:org-glaxosmithkline`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients (`cardio:pubmed-28228578`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b5a9dd74158c20f65497d86e9a52c4c94baa93e7bdfe7d68eaf66f9d58f9571b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
